COSCIENS Biopharma Statistics
Total Valuation
CSCI has a market cap or net worth of $9.34 million. The enterprise value is -$8.43 million.
Important Dates
The last earnings date was Tuesday, November 12, 2024, before market open.
Earnings Date | Nov 12, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
CSCI has 3.12 million shares outstanding. The number of shares has increased by 6.18% in one year.
Current Share Class | 3.12M |
Shares Outstanding | 3.12M |
Shares Change (YoY) | +6.18% |
Shares Change (QoQ) | +39.91% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 3.43M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/TBV Ratio | 0.51 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.46, with a Debt / Equity ratio of 0.08.
Current Ratio | 3.46 |
Quick Ratio | 2.70 |
Debt / Equity | 0.08 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -3,624.50 |
Financial Efficiency
Return on equity (ROE) is -100.27% and return on invested capital (ROIC) is -56.49%.
Return on Equity (ROE) | -100.27% |
Return on Assets (ROA) | -31.52% |
Return on Capital (ROIC) | -56.49% |
Revenue Per Employee | $402,833 |
Profits Per Employee | -$1.93M |
Employee Count | 12 |
Asset Turnover | 0.11 |
Inventory Turnover | 0.39 |
Taxes
Income Tax | -473,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -55.11% in the last 52 weeks. The beta is 2.27, so CSCI's price volatility has been higher than the market average.
Beta (5Y) | 2.27 |
52-Week Price Change | -55.11% |
50-Day Moving Average | 3.68 |
200-Day Moving Average | 6.08 |
Relative Strength Index (RSI) | 31.64 |
Average Volume (20 Days) | 6,805 |
Short Selling Information
The latest short interest is 5,116, so 0.16% of the outstanding shares have been sold short.
Short Interest | 5,116 |
Short Previous Month | 6,774 |
Short % of Shares Out | 0.16% |
Short % of Float | 0.15% |
Short Ratio (days to cover) | 1.64 |
Income Statement
In the last 12 months, CSCI had revenue of $4.83 million and -$23.21 million in losses. Loss per share was -$14.28.
Revenue | 4.83M |
Gross Profit | 4.17M |
Operating Income | -21.75M |
Pretax Income | -18.05M |
Net Income | -23.21M |
EBITDA | -21.60M |
EBIT | -21.75M |
Loss Per Share | -$14.28 |
Full Income Statement Balance Sheet
The company has $20.00 million in cash and $1.62 million in debt, giving a net cash position of $18.38 million or $5.89 per share.
Cash & Cash Equivalents | 20.00M |
Total Debt | 1.62M |
Net Cash | 18.38M |
Net Cash Per Share | $5.89 |
Equity (Book Value) | 20.01M |
Book Value Per Share | 6.41 |
Working Capital | 20.05M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$27.19 million and capital expenditures -$736,000, giving a free cash flow of -$27.93 million.
Operating Cash Flow | -27.19M |
Capital Expenditures | -736,000 |
Free Cash Flow | -27.93M |
FCF Per Share | -$8.94 |
Full Cash Flow Statement Margins
Gross Margin | 86.18% |
Operating Margin | -449.88% |
Pretax Margin | -489.90% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | -731.63% |